NCT02098109View on ClinicalTrials.gov

Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

August 20, 2014

Primary Completion Date

June 10, 2016

Study Completion Date

September 18, 2016

Conditions

Multiple MyelomaLymphoma, Non-Hodgkin

Interventions

DRUG

XM02 Filgrastim

DRUG

Filgrastim

PROCEDURE

Apheresis

DRUG

Plerixafor

PROCEDURE

Stem Cell Transplant

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

lead

Washington University School of Medicine

OTHER

NCT02098109 - Non-inferiority Study of XM02 Filgrastim (Granix) and Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma or Non-Hodgkin Lymphoma | Biotech Hunter | Biotech Hunter